Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125238061 | 12523806 | 1 | I | 20151226 | 20160620 | 20160704 | 20160704 | EXP | GB-MHRA-ADR 23519930 | GB-AXELLIA-000948 | XELLIA PHARMACEUTICALS | 2.00 | YR | F | Y | 0.00000 | 20160704 | OT | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125238061 | 12523806 | 1 | PS | VANCOMYCIN | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | RECEIVED 150 MG ON 22 TO 23-DEC-2015, THAN DOSE INCREASED TO 250 MG ON 23 TO 24-DEC-2015. | N | 91377 | 600 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125238061 | 12523806 | 1 | Pyrexia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125238061 | 12523806 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125238061 | 12523806 | Hyperkalaemia | |
125238061 | 12523806 | Renal impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125238061 | 12523806 | 1 | 20151225 | 20151226 | 0 |